Market Currents
Allergan (AGN +0.5%) moves up after Stifel Nicolaus raises its price target to $110 from $90 and...
-
Thursday, March 29, 2012, 12:48 PM ETAllergan (AGN +0.5%) moves up after Stifel Nicolaus raises its price target to $110 from $90 and reiterates a Buy ahead of its R&D day. The firm expects the company's newer products to generate tangible, sustainable growth.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles